BROWN RUDNICK LLP for HOSPIRA, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
S.1244 - FY14 FDA Appropriations bill relating to sequestered user fees.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | — |
Health Issues HCR
P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. Issues relating to generic drug labeling. HR. 1919- Safeguarding America's Pharmaceuticals Act of 2013 S. 957 & S. 959- The Drug Supply Chain of Security Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow(05-07) |
| HENRY W MENN | Min SD & Counsel, Cmte on Vet Affairs (04) |
Pharmacy PHA
H.R. 486- relating to the compounding of drug products House Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.